PAION AG is a publicly listed specialty pharmaceutical company with innovative drugs to be used in hospital-based sedation, anesthesia and critical care services. 

 

Learn more About PAION

Our Mission

PAION’s mission is to be a leading specialty pharmaceutical company in the fields of anesthesia and critical care by bringing novel products to market to benefit patients, doctors and other stakeholders in healthcare. 

PAION's Strategy & Partnering

AR 2020

Teleconference & webcast

31 March 2021

Replay

news

04/07/2021

PAION AG ANNOUNCES SUCCESSFUL COMPLETION OF CAPITAL INCREASE WITH SUBSCRIPTION...

DGAP-News: PAION AG / Key word(s): Capital Increase 07.04.2021 /...

Read more
04/07/2021

PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO (REMIMAZOLAM) IN SOUTH KOREA BY HANA...

DGAP-News: PAION AG / Key word(s): Market launch 07.04.2021 /...

Read more
03/30/2021

Annual financial report 2020 (includes Group and AG reports)

Annual financial report 2020 (includes Group and AG reports)

Read more

PAION Chart

Load Chart

I consent to the display of external content. This enables personal data to be transmitted to third-party platforms. Read more about our privacy policy.